Across TCGA pan-cancer cohorts, LINC02071 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LINC02071’s most consistent transcriptional readouts.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LINC02071 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02071 is over-expressed in tumor.
HNSC, LUSC, and KIRC are the cancer types where LINC02071 tumor–normal differential expression is most reproducible.